Long-awaited updates to the American College of Rheumatology's (ACR) guideline on systemic lupus erythematosus (SLE) ...

Q2 2026 Earnings Call Transcript November 10, 2025 Immunovant, Inc. misses on earnings expectations. Reported EPS is ...

Q2 2026 Earnings Call Transcript November 10, 2025 Roivant Sciences Ltd. beats earnings expectations. Reported EPS is ...

Long-term OGC use was associated with greater economic burden and higher complication rates among patients with DM or PM compared with short-term users.

Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...

Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...

A new option is now approved to treat adults living with high-risk smoldering multiple myeloma (MM). 1 The FDA has greenlit ...

A pooled analysis of two phase 3 clinical trials shows that the first-in-class drug improves itching and itching-related ...

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...

Efficacy and safety of subcutaneous self-administered gefurulimab in generalized myasthenia gravis: topline results from a ...

month data show patients with generalized myasthenia gravis taking efgartigimod were able to reduce glucocorticoids to low levels or discontinue them.

Much to the delight of ob-gyns long espousing the upsides of hormone therapy (a.k.a. hormone replacement therapy, or HRT) for ...